WaPo: “Staff in some Louisiana hospitals are doing timed drills, sprinting from patient rooms and through halls to the locked medicine closets where the drugs used for abortions, incomplete miscarriages and postpartum hemorrhaging will have to be kept — as newly categorized controlled substances — starting Oct. 1.
That’s hardly the only preparation taking place across the state as a law targeting mifepristone and misoprostol, the first of its kind in the country, goes into effect in two weeks.
Pharmacists are still trying to decipher guidance from state officials about the two drugs and the diagnosis codes that will be required before prescriptions for them can be filled. And they and doctors are speaking out about the extra layers of difficulty expected because of the law, which they worry will put patients experiencing serious pregnancy-related complications at even greater risk.”